Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oxford Biomedica Share News (OXB)
OXB Share
Price
OXB Share
News
OXB Share
Chat
OXB Share
Trades528
OXB
Live RNS
OXB Share
Charts
OXB Level 2
Console
OXB Live
Share Price
OXB Broker
Ratings
OXB Directors
Deals
OXB Financial
Diary
OXB
Fundamentals
OXB Short
Positions1
OXB
Media
OXB Company
Research
OXB Company
Timeline1
Oxford Biomedica Information
Share Price Information for Oxford Biomedica (OXB)
Share Price is delayed by 15 minutes
Get Live Data
600.00
-10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread:
2.00 (0.334%)
Market Cap:
£726.05m
Last checked at -
Last checked at 
Intraday Oxford Biomedica Share Chart
Oxford Biomedica News
20 Mar 2020
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares
19 Mar 2020
Oxford Biomedica Expects 2019 Loss As Chair Steps Down, Signs New Deal
Oxford Biomedica Expects 2019 Loss As Chair Steps Down, Signs New Deal
4 Feb 2020
Oxford Biomedica Sells USD8.4 Million In Orchard Therapeutics Shares
Oxford Biomedica Sells USD8.4 Million In Orchard Therapeutics Shares
19 Dec 2019
Oxford Biomedica Extends Agreement With Novartis By Five Years
Oxford Biomedica Extends Agreement With Novartis By Five Years
30 Sep 2019
BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE
BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE
28 May 2019
Novo Holdings pours ?53.5m into Oxford Biomedica
(Sharecast News) - Gene and cell therapy company Oxford Biomedica announced on Tuesday that Novo Holdings has agreed to invest up to £53.5m in the gro...
15 Mar 2019
Friday broker round-up
(Sharecast News) - Bakkavor Group: Berenberg downgrades to sell with a target price of 105p.
14 Mar 2019
Oxford Biomedica swings to positive earnings in 2018
(Sharecast News) - Gene and cell therapy group Oxford Biomedica reported a 72% increase in gross income in its preliminary results for the year ended ...
Follow the stocks
